Leveraging Functional Affinity Ligand Diversity To Deliver Rapid Affinity Resin-Based Purification Platforms To Diverse Biopharmaceuticals
- Utilizing affinity capture to create downstream manufacturing platforms from IND to commercialization
- Shaping product profile and potency through specific affinity resins that not only afford robust capture but actively select for features that confer product quality or avoid product variants
- Creating novel affinity resins compatible with legacy manufacturing infrastructure and newer next-generation manufacturing paradigms
- Case studies: Describing the use of peptide-based libraries to deliver high-selectivity affinity resins exclusively designed by bioprocess engineers with specific timelines and performance criteria